Macitentan and Tadalafil Combination Therapy in Patients with Pulmonary Arterial Hypertension and Cardiovascular Comorbidities: Real-World Evidence from OPUS and OrPHeUS
Authors
Nick H. Kim (ORCID: https://orcid.org/0000-0003-4702-650X)
Nicholas G. Martin (ORCID: https://orcid.org/0000-0003-4069-8020)
Gwen MacDonald
A. Senatore
Vallerie V. McLaughlin (ORCID: https://orcid.org/0000-0002-8907-1651)
Kelly Chin (ORCID: https://orcid.org/0000-0002-1214-6723)
Rose Ong (ORCID: https://orcid.org/0009-0005-0606-603X)
Richard Channick
Institutions
University of California, Los Angeles (US)
University of Michigan (US)
UC San Diego Health System (US)
University of California San Diego (US)
Southwestern Medical Center (US)
Southwestern Medical Center (US)
The University of Texas Southwestern Medical Center (US)
Macitentan and Tadalafil Combination Therapy in Patients with Pulmonary Arterial Hypertension and Cardiovascular Comorbidities: Real-World Evidence from OPUS and OrPHeUS
Nick H. Kim, Nicholas G. Martin, Gwen MacDonald, A. Senatore et al.
Journal
Advances in Therapy
Topics
Pulmonary Hypertension Research and Treatments
article
Macitentan and Tadalafil Combination Therapy in Patients with Pulmonary Arterial Hypertension and Cardiovascular Comorbidities: Real-World Evidence from OPUS and OrPHeUS
Nick H. Kim, Nicholas G. Martin, Gwen MacDonald, A. Senatore, Vallerie V. McLaughlin, Kelly Chin, Rose Ong, Richard Channick
article en
Abstract
No abstract available for this paper.
Publication Tag
Advances in TherapyVol. 42(7)
Institutions
University of California, Los Angeles (US), University of Michigan (US), UC San Diego Health System (US), University of California San Diego (US), Southwestern Medical Center (US), Southwestern Medical Center (US), The University of Texas Southwestern Medical Center (US), Actelion (Switzerland) (CH)